MD recognition by MDR gene regulators.

Area of Science:

• Biochemistry
• Structural Biology
• Molecular Biology

Background:

• Multidrug resistance (MDR) mechanisms are crucial for cellular defense against toxic compounds.
• These mechanisms rely on sensing and extruding a wide range of drugs.
• Key components include multidrug recognition (MD) and allosteric drug binding.

Purpose of the Study:

• To elucidate the structural basis of multidrug recognition in MDR transporters.
• To understand the interplay between drug binding and allosteric conformational changes.
• To provide a framework for interpreting structural data and proposing binding models.

Main Methods:

• X-ray crystallography of drug-bound protein complexes (BmrR, QacR, TtgR).
• Analysis of structural variations and drug-binding profiles.
• Development of binding models based on structural data.

Main Results:

• Crystal structures revealed detailed insights into canonical multidrug recognition.
• Structural data support both the canonical theme and variations in MD recognition.
• Multiple structures facilitated the proposal of binding models consistent with promiscuous drug binding.

Conclusions:

• The canonical view of multidrug recognition provides a useful framework for structural interpretation.
• Understanding these mechanisms is vital for combating MDR.
• Further structural studies will reveal alternative depictions of MD recognition.